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The UK National Institute for Health and 
Clinical Excellence (NICE) published 
guidelines on the diagnosis and 
management of open-angle glaucoma in 
2009 (www.nice.org.uk/CG85). These 
are intended to set standards for practice 
in the UK’s National Health Service (NHS)
As these guidelines are the only strictly 
evidence-based glaucoma guidelines 
available, however, they are a resource 
that can be accessed and used globally. 
To produce evidence-based guide-
lines, questions are asked about which 
diagnostic tests to use, or which treat-
ments to offer to particularl patients. High 
quality evidence is then systematically 
sought to answer those questions. When 
none is found, the consensus of the 
guideline development group is sought. 
When important gaps in the evidence 
base are found, recommendations for 
research are made.
Why	were	the	guidelines
needed?
The process of developing guidelines is 
costly in terms of human resources, time, 
and money, so there has to be a good 
reason to produce them. To put it mildly, 
glaucoma care in the NHS was far from 
ideal; there were wide variations in 
practice and standards and, inevitably, in 
outcomes. Over-diagnosis and missed 
diagnoses were also widespread, as were 
over-treatment and under-treatment. 
Every year, about 1,500 people with 
glaucoma are registered as blind in the 
UK. This is despite the fact that 
medication is available to preserve 
existing vision and delay or prevent the 
progression to blindness for most 
patients.
limitations	of	the	guidelines
It is important to remember that guidance 
is guidance, not a rigid protocol, and it is 
not comprehensive. It is ‘applicable to 
80% of cases, 80% of the time’. In 
addition, as mentioned in other articles in 
this issue, eye drops are not always a 
feasible form of treatment in low- and 
middle-income countries, and therefore 
the guidelines may not be as widely appli-
cable outside of the United Kingdom or 
Europe. 
The	NIcE	quality	standards
for	glaucoma
In addition to providing guidance to clini-
cians, it was also important to set 
standards for the delivery of glaucoma 
care (http://guidance.nice.org.uk/QS7). 
This is applicable to the information 
systems, referral pathways, communi-
cation, staff management, etc. needed to 
provide patients with consistently high 
levels of care. These standards, although 
not easily achievable in poorly resourced 
settings, do give us some ideas about 
what needs to be in place in our eye care 
or health care systems if we want to 
reduce avoidable blindness from 
glaucoma. Primarily, what is needed is a 
reasoned and coordinated approach:
‘The quality standard for glaucoma 
requires that services should be commis-
sioned from and coordinated across all 
relevant agencies encompassing the 
whole glaucoma care pathway, including 
primary, secondary and social care.
An integrated approach to provision of 
services is fundamental to the delivery
of high quality care to people with 
glaucoma. A local register of glaucoma-
related conditions, organised according 
to diagnosis, could be used to facilitate 
such integration.’ 
Those most at risk of blindness from 
glaucoma are those in the most deprived 
circumstances, including material and 
educational poverty. For example, in the 
Caribbean, wealthy people with 
glaucoma can afford diagnosis and 
treatment while those on average 
incomes will have little chance of saving 
their sight.
The huge challenge in poorer countries 
and emerging economies is to put in 
place the requirements for the ‘whole 
glaucoma pathway’. This is why 
preventing glaucoma blindness requires 
VISION 2020 programme s to achieve 
their highest potential by offering 
integrated and fully equipped services 
from primary to tertiary care. Thus the 
NICE standards are a remote ideal 
towards which all programmes should 
strive; the UK National Health Service 
(NHS) itself still has a long way to go.
For example, having local and/or 
national registers of glaucoma would 
help with the monitoring of standards, 
but this requires major infrastructural 
development. It would require a 
database that is secure in terms of infor-
mation governance but also technically 
sustainable and fully, regularly, and 
automatically backed up. It must be able 
to maintain individual records over the 
30-year natural history of the disease. 
However, basic beginnings can make an 
enormous difference. For example, on 
the island of Dominica, every person 
keeps an exercise book containing all 
their patient records; this is a useful 
solution when there are few resources.
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There are two major problems in most 
African nations. The first is the severe 
lack of ophthalmologists trained in the 
diagnosis and treatment of glaucoma. 
The second is the absence of national 
public awareness programmes about 
glaucoma. Any standards formulated to 
improve the outcome of glaucoma 
management in Africa must address 
these two issues. The development
of awareness among health care 
providers and the public is a must. The 
basic infrastructure needed for public 
awareness (TV, radio, newspapers), are 
available, but in the absence of govern-
mental interest, they are under-utilised. 
On the other hand, there is a real 
need for governmental involvement in 
the pricing of glaucoma medications. 
This is a global issue, but its impact is 
severely felt in under-developed 
countries. In some countries like Sudan, 
and for a variety of reasons, only a few 
drug companies have a market 
presence. As a result, patients do not 
have access to a good number of 
globally available glaucoma medications.
I think that, if the NICE guidelines are 
adapted by the WHO and used as the 
basis for a more comprehensive global 
guideline for glaucoma care, then more 
governments and health authorities can 
use them. More importantly, advocates 
for a better global care for glaucoma 
patients will then have a tool to use to 
convince policy makers to take action.
A response from Africa
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